Jeremy D Keenan1,2, Stephanie A Chin1, Abdou Amza3, Boubacar Kadri3, Baido Nassirou3, Vicky Cevallos1, Sun Y Cotter1, Zhaoxia Zhou1, Sheila K West4, Robin L Bailey5, Travis C Porco1,2,6, Thomas M Lietman1,2,6,7. 1. Francis I. Proctor Foundation, University of California, San Francisco. 2. Department of Ophthalmology, University of California, San Francisco. 3. Programme National de Lutte Contre la Cecité, Niamey, Niger. 4. Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland. 5. Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom. 6. Department of Epidemiology and Biostatistics, University of California, San Francisco. 7. Institute for Global Health, University of California, San Francisco.
Abstract
Background: Frequent use of antibiotics is thought to create selection pressure by clearing susceptible bacteria and allowing resistant bacteria to spread in a community. A cluster-randomized trial comparing 2 different frequencies of mass azithromycin distributions for trachoma provided a convenient experiment for determining the causal relationship between antibiotic consumption and antibiotic resistance. Methods:Twenty-four communities were randomized to either annual or biannual mass azithromycin distributions for trachoma. Randomization was stratified on health catchment area and trachoma prevalence. Swabs were processed for the genetic macrolide resistance determinants ermB and mefA/E in a masked fashion from a random sample of 120 preschool children before treatment and another 120 children after 2 years of mass antibiotics. Results:Macrolide resistance determinants were similar in the 12 annually and 12 biannually treated communities before treatment, with a median prevalence among preschool children of 20% (interquartile range [IQR], 10%-40%) in each group. By 24 months, macrolide resistance determinants were found more commonly in the biannually treated communities (median, 60% [IQR, 50%-80%]) than the annually treated communities (median, 40% [IQR, 20%-40%]; P < .001). Adjusting for baseline, the 24-month prevalence of macrolide resistance determinants in the biannual group was 29.4% higher than that of the annual group (95% confidence interval, 10.5%-56.7%). Conclusions: This randomized trial used direct genetic methods to confirm the causal relationship of community antibiotic consumption and antibiotic resistance. Communities randomized to less frequent use of antibiotics had a significantly lower prevalence of genetic antibiotic resistance determinants. Clinical Trials Registration: NCT00792922.
RCT Entities:
Background: Frequent use of antibiotics is thought to create selection pressure by clearing susceptible bacteria and allowing resistant bacteria to spread in a community. A cluster-randomized trial comparing 2 different frequencies of mass azithromycin distributions for trachoma provided a convenient experiment for determining the causal relationship between antibiotic consumption and antibiotic resistance. Methods: Twenty-four communities were randomized to either annual or biannual mass azithromycin distributions for trachoma. Randomization was stratified on health catchment area and trachoma prevalence. Swabs were processed for the genetic macrolide resistance determinants ermB and mefA/E in a masked fashion from a random sample of 120 preschool children before treatment and another 120 children after 2 years of mass antibiotics. Results:Macrolide resistance determinants were similar in the 12 annually and 12 biannually treated communities before treatment, with a median prevalence among preschool children of 20% (interquartile range [IQR], 10%-40%) in each group. By 24 months, macrolide resistance determinants were found more commonly in the biannually treated communities (median, 60% [IQR, 50%-80%]) than the annually treated communities (median, 40% [IQR, 20%-40%]; P < .001). Adjusting for baseline, the 24-month prevalence of macrolide resistance determinants in the biannual group was 29.4% higher than that of the annual group (95% confidence interval, 10.5%-56.7%). Conclusions: This randomized trial used direct genetic methods to confirm the causal relationship of community antibiotic consumption and antibiotic resistance. Communities randomized to less frequent use of antibiotics had a significantly lower prevalence of genetic antibiotic resistance determinants. Clinical Trials Registration: NCT00792922.
Authors: Thuy Doan; Teshome Gebre; Berhan Ayele; Mulat Zerihun; Armin Hinterwirth; Lina Zhong; Cindi Chen; Kevin Ruder; Zhaoxia Zhou; Paul M Emerson; Travis C Porco; Jeremy D Keenan; Thomas M Lietman Journal: Cornea Date: 2021-09-03 Impact factor: 3.152
Authors: Jennifer R Evans; Anthony W Solomon; Rahul Kumar; Ángela Perez; Balendra P Singh; Rajat Mohan Srivastava; Emma Harding-Esch Journal: Cochrane Database Syst Rev Date: 2019-09-26
Authors: Leigh M Howard; Keerti L Dantuluri; Nicole Soper; Isaac P Thomsen; Carlos G Grijalva Journal: Open Forum Infect Dis Date: 2021-10-16 Impact factor: 3.835
Authors: Rebecca A Gladstone; Ebrima Bojang; John Hart; Emma M Harding-Esch; David Mabey; Ansumana Sillah; Robin L Bailey; Sarah E Burr; Anna Roca; Stephen D Bentley; Martin J Holland Journal: Clin Microbiol Infect Date: 2020-08-01 Impact factor: 8.067
Authors: Soumeya Hema-Ouangraoua; Abdoul Aziz Maiga; Matthew Cairns; Issaka Zongo; Nikiema Frédéric; Rakiswendé Serge Yerbanga; Boubou Tamboura; Henry Badji; Georgia Gore-Langton; Irene Kuepfer; Halidou Tinto; Issaka Sagara; Alassane Dicko; Samba O Sow; Daniel Chandrahoman; Brian Greenwood; Jean Bosco Ouedraogo Journal: Trop Med Int Health Date: 2019-11-13 Impact factor: 2.622
Authors: M M Pettigrew; J Kwon; J F Gent; Y Kong; M Wade; D J Williams; C B Creech; S Evans; Q Pan; E B Walter; J M Martin; J S Gerber; J G Newland; M E Hofto; M A Staat; V G Fowler; H F Chambers; W C Huskins Journal: mBio Date: 2022-03-24 Impact factor: 7.786